Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2004

View Archived Issues

Galenica acquisition finalized

Final phase of Estrasorb commercial launch

Vernalis and Biogen Idec collaborate on adenosine A2A receptor antagonists

Isis earns milestone for Macugen NDA filing

Palifermin NDA submitted for oral mucositis

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

First clinical trial of HER-2/neu-based vaccine in patients with breast and ovarian cancer

Preliminary data on Exherin in patients with solid tumors

Six related series of opioid analgesics presented by Gruenenthal

BMS researchers describe three series of anti-HIV agents

Lilly claims novel 5-HT/norepinephrine reuptake inhibitors for pain and other uses

Two series of immunomodulating agents newly described by BMS scientists

French researchers identify new protein kinase modulators for diabetes, cancer, etc.

Servier presents new AMPK activators with potential in diabetes and other disorders

Manhattan Pharmaceuticals investigates oleoyl estrone for weight control

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

Incara changes company name to Aeolus Pharmaceuticals

Advanced Magnetics submits response to Combidex approvable letter

FDA extends action date for Cymbalta

Nabi files for European approval of Nabi-HB Intravenous

U. of Pittsburgh to test AAB-001 for Alzheimer's

Preliminary phase II results for DB-289 in Pneumocystis carinii pneumonia

Approvable letter for oxypurinol for allopurinol-intolerant hyperuricemia

Alimta receives positive opinion in Europe

Phase III PREVENT IV edifoligide study recommended to continue

Immunization completed in phase I ragweed allergy immunotherapy study

NDA submission for new 500 mg formulation of Invirase

New rapid disintegration Aricept formulation launched in Japan

Japanese launch for Serevent 50 Diskus

Mitemcinal reported safe and effective for treating gastroparesis

Preclinical evidence for the effects of rimonabant on body weight and food intake

The efficacy of vardenafil in ED is not affected by glycemic control or diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...